Quotient Therapeutics
Focus: Quotient Therapeutics is a Cambridge-based biotech specializing in genetic library technology for drug discovery and development, currently focused on rare disease applications.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
82+25 this month
Hot — 76 jobs added in 30d
Net +25 (76 new, 51 removed). Aggressive expansion phase.
Should You Work at Quotient Therapeutics?
AI assessmentHigh-growth, high-risk early-stage platform play best suited for scientists and engineers comfortable with discovery-phase work and equity upside uncertainty.
Why Work Here
- 78 active job openings signal aggressive expansion, particularly in R&D (27 roles) and Data Science (11 roles) with perfect H1B approval record (5/5 in 2023)
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ID-Capsule- Active
Healthy VolunteersClinical Trials (1)
NCT03653897Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication Adherence
N/AHelp build intelligence for Quotient Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.